Intelence FDA Approval History
FDA Approved: Yes (First approved January 18, 2008)
Brand name: Intelence
Generic name: etravirine
Dosage form: Tablets
Previous Name: TMC125
Company: Tibotec Pharmaceuticals Ltd.
Treatment for: HIV Infection
Intelence (etravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.
Development Timeline for Intelence
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.